ppat.1008473.s003.tif (268.92 kB)

ZBP1-expressing HT-29s with T+S+V retain the ability to undergo necroptosis.

Download (268.92 kB)
posted on 10.07.2020 by Megan Steain, Max O. D. G. Baker, Chi L. L. Pham, Nirukshan Shanmugam, Yann Gambin, Emma Sierecki, Brian P. McSharry, Selmir Avdic, Barry Slobedman, Margaret Sunde, Allison Abendroth

ZBP1 expressing HT-29s were treated with DMSO (No treatment, NT) or with TNF (T; 30 ng/ml), BV-6 (S; 1 μM), z-VAD-fmk (V; 25 μM) for 18 h then cell viability measured using the Promega Cell Titre Glo2 assay.